In human AML cell lines, TRKA expression has been reported in erythroleukemic subtypes and can support proliferation of these cell lines with exogenous NGF in place of the typically required granulocyte-monocyte colony-stimulating factor (GM-CSF) [11]. This evidence concerns the gene NTRK1 and acute myeloid leukemia.